SESTRIN 2 AS A NOVEL THERAPEUTIC TARGET AND BIOLOGICAL MARKER IN DIABETIC NEPHROPATHY

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)

Gorin,Yves

Funded by

QATAR UNIVERSITY

Research Start Date

01/01/2017

Status

Active

Clinical Care

Diabetes and Obesity

Bioscience Research Panel